David Hoang

Stock Analyst at Deutsche Bank

(0)
# 4533
Out of 5,329 analysts
43
Total ratings
24.00%
Success rate
-16.47%
Average return
21 Stocks
Name Action PT Current % Upside Ratings Updated
ALKS Alkermes
Maintains: Strong Buy
40 52
30.63 69.77% 2 Mar 27, 2025
SRPT Sarepta Therapeutics
Maintains: Hold
124 99
62.8 57.64% 6 Mar 19, 2025
XENE Xenon Pharmaceutical...
Initiates Coverage On: Buy
67
38.18 75.48% 3 Feb 11, 2025
PRAX Praxis Precision Med...
Initiates Coverage On: Buy
111
38.16 190.88% 1 Feb 11, 2025
HRMY Harmony Biosciences
Initiates Coverage On: Buy
55
29.9 83.95% 2 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
31
16.11 92.43% 3 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
65
22.56 188.12% 1 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
176
112.47 56.49% 4 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
12
8.62 39.21% 1 Feb 11, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
30 23
14.59 57.64% 4 Aug 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
150 158
106.71 48.06% 4 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
45 50
n/a n/a 3 Aug 2, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
7
1.07 554.21% 1 Jul 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Sell
8
7.5 6.67% 1 May 29, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
16
3.66 337.16% 1 Mar 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
16
3.58 346.93% 1 Mar 7, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
220
255.12 -13.77% 1 Apr 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
80
14.06 468.99% 1 Apr 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
15 25
n/a n/a 1 Mar 14, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
3
1.04 188.46% 1 Dec 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Apr 1, 2022